EU a step closer to defining nanomaterials
This article was originally published in RAJ Devices
Executive Summary
The European Commission has launched a public consultation on the definition of the term "nanomaterials" now that its Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) has published a preliminary opinion on the matter1,2. The consultation aims to achieve a science-based working definition, which is viewed as critical for the development of policy and regulatory activities on nanotechnologies, including nanomedicine. The deadline for submitting comments is 15 September.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.